Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8.

Identifieur interne : 001D07 ( PubMed/Corpus ); précédent : 001D06; suivant : 001D08

The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8.

Auteurs : Monique Oostra ; Cornelis A M. De Haan ; Peter J M. Rottier

Source :

RBID : pubmed:17928347

English descriptors

Abstract

One of the most striking and dramatic genomic changes observed in the severe acute respiratory syndrome coronavirus (SARS-CoV) isolated from humans soon after its zoonotic transmission from palm civets was the acquisition of a characteristic 29-nucleotide deletion. This occurred in open reading frame 8 (ORF8), one of the accessory genes unique to the SARS-CoV. The function of ORF8 and the significance of the deletion are unknown. The intact ORF8 present in animal and some early human isolates encodes a 122-amino-acid polypeptide (8ab(+)), which we expressed in cells using the vaccinia virus T7 expression system. It was found to contain a cleavable signal sequence, which directs the precursor to the endoplasmic reticulum (ER) and mediates its translocation into the lumen. The cleaved protein became N-glycosylated, assembled into disulfide-linked homomultimeric complexes, and remained stably in the ER. The 29-nucleotide deletion splits ORF8 into two ORFs, 8a and 8b, encoding 39- and 84-residue polypeptides. The 8a polypeptide is likely to remain in the cytoplasm, as it is too small for its signal sequence to function and will therefore be directly released from the ribosome. However, we could not confirm this experimentally due to the lack of proper antibodies. ORF8b appeared not to be expressed in SARS-CoV-infected cells or when expressed from mRNA's mimicking mRNA8. This was due to the context of the internal AUG initiation codon, as we demonstrated after placing the ORF8b immediately behind the T7 promoter. A soluble, unmodified and monomeric 8b protein was now expressed in the cytoplasm, which was highly unstable and rapidly degraded. Clearly, the 29-nucleotide deletion disrupts the proper expression of the SARS-CoV ORF8, the implications of which are discussed.

DOI: 10.1128/JVI.01631-07
PubMed: 17928347

Links to Exploration step

pubmed:17928347

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8.</title>
<author>
<name sortKey="Oostra, Monique" sort="Oostra, Monique" uniqKey="Oostra M" first="Monique" last="Oostra">Monique Oostra</name>
<affiliation>
<nlm:affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="De Haan, Cornelis A M" sort="De Haan, Cornelis A M" uniqKey="De Haan C" first="Cornelis A M" last="De Haan">Cornelis A M. De Haan</name>
</author>
<author>
<name sortKey="Rottier, Peter J M" sort="Rottier, Peter J M" uniqKey="Rottier P" first="Peter J M" last="Rottier">Peter J M. Rottier</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17928347</idno>
<idno type="pmid">17928347</idno>
<idno type="doi">10.1128/JVI.01631-07</idno>
<idno type="wicri:Area/PubMed/Corpus">001D07</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001D07</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8.</title>
<author>
<name sortKey="Oostra, Monique" sort="Oostra, Monique" uniqKey="Oostra M" first="Monique" last="Oostra">Monique Oostra</name>
<affiliation>
<nlm:affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="De Haan, Cornelis A M" sort="De Haan, Cornelis A M" uniqKey="De Haan C" first="Cornelis A M" last="De Haan">Cornelis A M. De Haan</name>
</author>
<author>
<name sortKey="Rottier, Peter J M" sort="Rottier, Peter J M" uniqKey="Rottier P" first="Peter J M" last="Rottier">Peter J M. Rottier</name>
</author>
</analytic>
<series>
<title level="j">Journal of virology</title>
<idno type="eISSN">1098-5514</idno>
<imprint>
<date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Gene Expression Regulation, Viral</term>
<term>Humans</term>
<term>Molecular Sequence Data</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (isolation & purification)</term>
<term>SARS Virus (physiology)</term>
<term>Sequence Deletion</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Species Specificity</term>
<term>Vero Cells</term>
<term>Viral Matrix Proteins (chemistry)</term>
<term>Viral Matrix Proteins (genetics)</term>
<term>Viral Matrix Proteins (metabolism)</term>
<term>Viral Proteins (chemistry)</term>
<term>Viral Proteins (genetics)</term>
<term>Viral Proteins (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Viral Matrix Proteins</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>SARS Virus</term>
<term>Viral Matrix Proteins</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Viral Matrix Proteins</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Gene Expression Regulation, Viral</term>
<term>Humans</term>
<term>Molecular Sequence Data</term>
<term>Sequence Deletion</term>
<term>Species Specificity</term>
<term>Vero Cells</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">One of the most striking and dramatic genomic changes observed in the severe acute respiratory syndrome coronavirus (SARS-CoV) isolated from humans soon after its zoonotic transmission from palm civets was the acquisition of a characteristic 29-nucleotide deletion. This occurred in open reading frame 8 (ORF8), one of the accessory genes unique to the SARS-CoV. The function of ORF8 and the significance of the deletion are unknown. The intact ORF8 present in animal and some early human isolates encodes a 122-amino-acid polypeptide (8ab(+)), which we expressed in cells using the vaccinia virus T7 expression system. It was found to contain a cleavable signal sequence, which directs the precursor to the endoplasmic reticulum (ER) and mediates its translocation into the lumen. The cleaved protein became N-glycosylated, assembled into disulfide-linked homomultimeric complexes, and remained stably in the ER. The 29-nucleotide deletion splits ORF8 into two ORFs, 8a and 8b, encoding 39- and 84-residue polypeptides. The 8a polypeptide is likely to remain in the cytoplasm, as it is too small for its signal sequence to function and will therefore be directly released from the ribosome. However, we could not confirm this experimentally due to the lack of proper antibodies. ORF8b appeared not to be expressed in SARS-CoV-infected cells or when expressed from mRNA's mimicking mRNA8. This was due to the context of the internal AUG initiation codon, as we demonstrated after placing the ORF8b immediately behind the T7 promoter. A soluble, unmodified and monomeric 8b protein was now expressed in the cytoplasm, which was highly unstable and rapidly degraded. Clearly, the 29-nucleotide deletion disrupts the proper expression of the SARS-CoV ORF8, the implications of which are discussed.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">17928347</PMID>
<DateCompleted>
<Year>2007</Year>
<Month>12</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>12</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1098-5514</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>81</Volume>
<Issue>24</Issue>
<PubDate>
<Year>2007</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of virology</Title>
<ISOAbbreviation>J. Virol.</ISOAbbreviation>
</Journal>
<ArticleTitle>The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8.</ArticleTitle>
<Pagination>
<MedlinePgn>13876-88</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>One of the most striking and dramatic genomic changes observed in the severe acute respiratory syndrome coronavirus (SARS-CoV) isolated from humans soon after its zoonotic transmission from palm civets was the acquisition of a characteristic 29-nucleotide deletion. This occurred in open reading frame 8 (ORF8), one of the accessory genes unique to the SARS-CoV. The function of ORF8 and the significance of the deletion are unknown. The intact ORF8 present in animal and some early human isolates encodes a 122-amino-acid polypeptide (8ab(+)), which we expressed in cells using the vaccinia virus T7 expression system. It was found to contain a cleavable signal sequence, which directs the precursor to the endoplasmic reticulum (ER) and mediates its translocation into the lumen. The cleaved protein became N-glycosylated, assembled into disulfide-linked homomultimeric complexes, and remained stably in the ER. The 29-nucleotide deletion splits ORF8 into two ORFs, 8a and 8b, encoding 39- and 84-residue polypeptides. The 8a polypeptide is likely to remain in the cytoplasm, as it is too small for its signal sequence to function and will therefore be directly released from the ribosome. However, we could not confirm this experimentally due to the lack of proper antibodies. ORF8b appeared not to be expressed in SARS-CoV-infected cells or when expressed from mRNA's mimicking mRNA8. This was due to the context of the internal AUG initiation codon, as we demonstrated after placing the ORF8b immediately behind the T7 promoter. A soluble, unmodified and monomeric 8b protein was now expressed in the cytoplasm, which was highly unstable and rapidly degraded. Clearly, the 29-nucleotide deletion disrupts the proper expression of the SARS-CoV ORF8, the implications of which are discussed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Oostra</LastName>
<ForeName>Monique</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Virology Division, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>de Haan</LastName>
<ForeName>Cornelis A M</ForeName>
<Initials>CA</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Rottier</LastName>
<ForeName>Peter J M</ForeName>
<Initials>PJ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2007</Year>
<Month>10</Month>
<Day>10</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Virol</MedlineTA>
<NlmUniqueID>0113724</NlmUniqueID>
<ISSNLinking>0022-538X</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014763">Viral Matrix Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C488151">sars7a protein, SARS virus</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015967" MajorTopicYN="Y">Gene Expression Regulation, Viral</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D017384" MajorTopicYN="Y">Sequence Deletion</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014763" MajorTopicYN="N">Viral Matrix Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2007</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2007</Year>
<Month>12</Month>
<Day>28</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2007</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">17928347</ArticleId>
<ArticleId IdType="pii">JVI.01631-07</ArticleId>
<ArticleId IdType="doi">10.1128/JVI.01631-07</ArticleId>
<ArticleId IdType="pmc">PMC2168875</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Virol. 2004 Dec;78(24):14043-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15564512</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Biochem Sci. 1990 Dec;15(12):483-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2077689</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Mar;79(5):3182-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15709039</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Emerg Infect Dis. 2005 Jan;11(1):168-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15714661</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2005 Apr 29;330(1):286-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15781262</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Sep;79(17):11335-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16103185</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virol J. 2005;2:66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16107218</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16169905</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Gene Ther. 2005 Oct;5(5):523-30</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16250892</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Dec;79(23):14909-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16282490</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Parasitology. 2005;130 Suppl:S11-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16281988</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Mar;80(5):2326-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16474139</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2006 Mar 1;346(1):74-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16303160</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS Lett. 2006 Jun 26;580(15):3643-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16753150</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2006 Aug;80(15):7287-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16840309</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2006 Oct 10;354(1):132-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16876844</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Adv Immunol. 2006;92:225-305</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17145306</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Jan;81(2):718-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17079322</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2007 Jan;81(2):548-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17108024</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Immunol Cell Biol. 2007 Feb-Mar;85(2):93-102</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17228320</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect Dis. 2007 Aug 1;196(3):405-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17597455</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>FEBS J. 2007 Aug;274(16):4211-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17645546</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Gene. 1991 Dec 15;108(2):201-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1660838</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2000 Mar 30;269(1):172-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10725209</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12289-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11027311</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2001 Jan 20;279(2):375-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11162793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2001 May 10;283(2):230-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11336548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2002 Apr 25;296(1):177-89</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12036329</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2002 Sep;8(9):950-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12195436</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1992 Aug;66(8):4951-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1321279</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 1992 Oct;66(10):6143-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1527853</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 1994 Nov;75 ( Pt 11):3041-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7964613</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2003 Mar 30;308(1):13-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12706086</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Virology. 2003 May 10;309(2):181-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12758165</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2003 Aug;77(15):8426-39</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12857912</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12892955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2003 Sep;84(Pt 9):2305-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12917450</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2003 Oct 10;302(5643):276-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12958366</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2003 Oct 30;425(6961):915</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14586458</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2004 Mar 12;303(5664):1666-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14752165</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Apr;78(8):3863-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15047802</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Apr;78(8):4363-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15047850</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2004 Jul;78(13):6723-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15194747</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1986 Nov;83(21):8122-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3095828</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Biol. 1987 Aug 20;196(4):947-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3681984</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Biol. 1989 Feb;108(2):229-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2645293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1990 May 5;265(13):7478-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2185250</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 1990 Sep;87(17):6743-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2204064</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Virol. 2005 Feb;79(4):2620-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15681462</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D07 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001D07 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:17928347
   |texte=   The 29-nucleotide deletion present in human but not in animal severe acute respiratory syndrome coronaviruses disrupts the functional expression of open reading frame 8.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:17928347" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021